Ronald Samuel

Featured in: Favicon

gastrojournal.org

Articles

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Sep 16, 2024 | jamanetwork.com | Fasiha Kanwal |Jennifer Kramer |Ronald Samuel

Key PointsQuestion Is use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) associated with lower incidence of cirrhosis and its complications in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)?
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Sep 16, 2024 | jamanetwork.com | Fasiha Kanwal |Jennifer Kramer |Ronald Samuel

Key PointsQuestion Is use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) associated with lower incidence of cirrhosis and its complications in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)?

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →